The Demand Signal: Biotech

Procurement intelligence from OODA · Reading what government intends to buy.

Chemical, Biological, Radiological, and Nuclear (CBRN) Medical Countermeasure (MCM) Participant Basic Agreement (PBA)

Department of Defense · DEPT OF THE ARMY · Special Notice · W911SR-26-R-HEAL

posted 21 July 2026 · NAICS 541714 · PSC AC13 · 6 postings

Summary

The Department of the Army is issuing a continuous open announcement for participants to enter into a CBRN Medical Countermeasure (MCM) Participant Basic Agreement (PBA) ecosystem, which will pre‑qualify partners to develop, test and field next‑generation chemical, biological, radiological and nuclear medical defenses. The effort seeks innovative therapeutic candidates, delivery platforms and support services that can be rapidly employed in austere environments, emphasizing advanced biotechnology for warfighter protection.

View the official notice ↗

Want to know why the government is buying what they buy? Subscribe to the OODA Daily Pulse

The OODA Daily Pulse Report provides a detailed summary of the top technology, cybersecurity and global risks of the day. Our analysts curate stories, articles and insights from hundreds of vetted sources to inform your decisions and our research team provides long form context on topics destined to be of importance. Delivered free to your inbox five days a week at 10:00am.

Subscribe to the OODA Daily Pulse